Meta-analysis demonstrates superior diagnostic performance combining glypican 3 with alpha-fetoprotein in hepatocellular carcinoma, suggesting improved differentiation from liver cirrhosis.
Serum GPC3 is inferior to AFP in the differential diagnosis between HCC and LC. However, the combination of GPC3 and AFP exhibited a much better performance.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: